M
Mark W. Mewissen
Researcher at Medical College of Wisconsin
Publications - 33
Citations - 1984
Mark W. Mewissen is an academic researcher from Medical College of Wisconsin. The author has contributed to research in topics: Angioplasty & Stent. The author has an hindex of 14, co-authored 27 publications receiving 1916 citations. Previous affiliations of Mark W. Mewissen include Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry.
Mark W. Mewissen,Gary R. Seabrook,Mark H. Meissner,Jacob Cynamon,Nicos Labropoulos,Signe H. Haughton +5 more
TL;DR: Catheter-directed thrombolysis is safe and effective for treatment of symptomatic lower extremity deep venous thrombosis (DVT), andysis grade was predictive of 1-year patency rate.
Journal ArticleDOI
Detection of pulmonary embolism in patients with unresolved clinical and scintigraphic diagnosis: helical CT versus angiography.
Lawrence R. Goodman,J J Curtin,Mark W. Mewissen,W D Foley,Randolph J. Lipchik,Martin R. Crain,K B Sagar,Collier Bd +7 more
TL;DR: Helical CT was only 63% sensitive in a subset of patients and subsegmental emboli are difficult to diagnose, suggesting a limited role in the evaluation of acute pulmonary embolism.
Journal ArticleDOI
Fibrin sleeve stripping for salvage of failing hemodialysis catheters: technique and initial results.
Martin R. Crain,Mark W. Mewissen,G J Ostrowski,Ricardo Paz-Fumagalli,Robert A. Beres,R A Wertz +5 more
TL;DR: Multiple PFSS procedures can prolong patency in hemodialysis catheters with a fibrin sleeve in patients with an inadequate blood flow rate during he modialysis.
Journal ArticleDOI
Self-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results
TL;DR: Objective evidence is provided that endovascular treatment of FP TASC A, B and C lesions using self-expanding nitinol SMART stents in patients with chronic limb ischemia provides favorable safety and durability outcomes.
Journal ArticleDOI
Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study.
Kenneth Ouriel,Barry Katzen,Mark W. Mewissen,Pamela A. Flick,Daniel G. Clair,James E. Benenati,Thomas O. McNamara,Douglas Gibbens +7 more
TL;DR: Although there was no association between the dose regimen and thrombolytic efficacy, bleeding complications appeared to be more frequent as the dose was increased from 0.5 to 2.0 U/h, reteplase appears to be an acceptable alternative thrombotic agent with a satisfactory safety and efficacy profile in the setting of peripheral arterial and venous occlusion.